MIDRANGE dot COM Mailing List Archive



Home » MIDRANGE-L » May 1999

Re: ILE RPG & variable length fields


  • Subject: Re: ILE RPG & variable length fields
  • From: "Steven Easton" <seaston@xxxxxxxxx>
  • Date: Fri, 28 May 1999 21:14:32 -0500

fixed

Try converting an existing file (like customer master) to variable length.
Copy the data to the new file.  compare the size of the old flat file with
the new variable file.  The flat file takes up less room and saves cpu
cycles too.
-----Original Message-----
From: Jim Franz <franz99@ibm.net>
To: MIDRANGE-L@midrange.com <MIDRANGE-L@midrange.com>
Date: Tuesday, May 04, 1999 11:33 PM
Subject: ILE RPG & variable length fields


>I am trying my 1st with variable length fields, but having problems if a
>variable length field is a key field, even a key field within a logical
>view. Is this possible? I'd like to setll & read on a logical, where the
>var len might be the 1st key field. Appreciate any help. jim
>
>(sorry for a previous response I sent, I think my e-mail quoted a whole
>afternoon's worth of q&a).
>
>+---
>| This is the Midrange System Mailing List!
>| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
>| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
>| To unsubscribe from this list send email to
MIDRANGE-L-UNSUB@midrange.com.
>| Questions should be directed to the list owner/operator:
david@midrange.com
>+---
>

+---
| This is the Midrange System Mailing List!
| To submit a new message, send your mail to MIDRANGE-L@midrange.com.
| To subscribe to this list send email to MIDRANGE-L-SUB@midrange.com.
| To unsubscribe from this list send email to MIDRANGE-L-UNSUB@midrange.com.
| Questions should be directed to the list owner/operator: david@midrange.com
+---






Return to Archive home page | Return to MIDRANGE.COM home page

This mailing list archive is Copyright 1997-2014 by MIDRANGE dot COM and David Gibbs as a compilation work. Use of the archive is restricted to research of a business or technical nature. Any other uses are prohibited. Full details are available here. If you have questions about this, please contact